Craig Coleman
Professor/Pharmacy Practice

Are you Craig Coleman?

How to update your information.
Case studies (February 2018)
2018
Elliott A. Bosco, Craig Coleman
Research Type: Other Scholarly Work

Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma
2018
Charles M White, K V Blake, Diana Sobieraj, Craig Coleman, S C Lazarus, William L Baker Jr., E R Weeda, E Nguyen, J E Lang
Research Type: Other Scholarly Work

Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: The Improve-VTE Study
2018
Research Type: Poster/Presentation

Effectiveness and Safety of Rivaroxaban versus Low Molecular-weight Heparin for Treatment of Cancer-associated Thromboembolism
2018
Research Type: Poster/Presentation

Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban versus Warfarin in Patients With Nonvalvular Atrial Fibrillation
2018
Research Type: Poster/Presentation

Translating real world evidence into your clinical practice for your multi-morbid patient
2018
Research Type: Poster/Presentation

Effectiveness and Safety of Outpatient Rivaroxaban versus Warfarin in Patients with Provoked Acute Venous Thromboembolism
2018
Research Type: Poster/Presentation

Comparative Efficacy and Safety of Anticoagulation for the Treatment of Cancer-associated Thrombosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials
2018
Research Type: Poster/Presentation

Cost and Inpatient Burden of Peripheral Artery Disease: Findings From the National Inpatient Sample
2018
Research Type: Poster/Presentation

Indexing performance measure codes to enhance perceived value of EPC reports.
2018
Stephanie Chang, Lionel Banez, Brandon Martinez, Charles M White, Craig Coleman
Research Type: Poster/Presentation

Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients with Nonvalvular Atrial Fibrillation and Heart Failure
2018
Research Type: Poster/Presentation

Comparative Risk of Major Bleeding With Rivaroxaban and Warfarin: Population Based Cohort Study of Unprovoked Venous Thromboembolism
2018
Research Type: Poster/Presentation

Evidence Summary
2019
Adrian V Hernandez Diaz, Craig Coleman, Brandon K Martinez, Mark X Cicero, Richard A Kamin, Diana Sobieraj, Benjamin Miao, William L Baker Jr.
Research Type: Book Chapter

Treatment patterns, glycemic control & bodyweight with canagliflozin 300 mg versus GLP1RAs in Type II diabetes patients.
2019
O Baser, Craig Coleman, L Wang, J Cai, M Ingham, S Pandya, B Bookhart
Research Type: Journal Article

The impact of non-medical switching among ambulatory patients: an updated systematic literature review.
2019
M Ingham, S Martin, E Nguyen, E R Weeda, B K Bookhart, Craig Coleman, Diana Sobieraj
Research Type: Journal Article

Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care.
2019
C Crivera, J Schein, W F Peacock, G J Fermann, O Baser, P Wells, L Wang, Craig Coleman
Research Type: Journal Article

Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation.
2019
D Eriksson, B K Martinez, Craig Coleman, N A Sood, William L Baker Jr., A K Meinecke, Thomas Bunz
Research Type: Journal Article

Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults.
2019
D C Steffens, Craig Coleman, K M Berg, A V Hernandez, Diana Sobieraj, William L Baker Jr., B K Martinez, J S Ross
Research Type: Journal Article

The value of sPESI for risk stratification in patients with pulmonary embolism.
2019
O Baser, J Schein, Craig Coleman, P Wells, C Crivera, W F Peacock, L Wang, G J Fermann
Research Type: Journal Article

Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation.
2019
J B Briere, L Fauchier, P Levy, O Wu, A Millier, K Bowrin, M Toumi, V Taieb, Craig Coleman
Research Type: Journal Article